News and Announcements
From Private to ASX Listed: How Ray Mountfort Raised Over $6 Million During COVID
- Published June 27, 2023 11:00PM UTC
- Publisher Wholesale Investor
- Categories Capital Raising Tips
Embark on an extraordinary journey with Ray Mountfort, Founder of Essential Queensland, as he shares his remarkable story of raising over $6 million during the challenging times of the COVID-19 pandemic. In this captivating video, Ray takes us through his transformative experience, providing invaluable insights and practical advice for founders in more technical industries.
Ray reveals the strategies that propelled his company’s growth and enabled him to transition from a private company to an ASX listed entity. Gain a deeper understanding of the unique challenges faced by founders during COVID-19 and learn how to navigate the complexities of raising capital successfully.
Discover the secrets to making room for investors and creating opportunities even in uncertain times. Ray’s firsthand experiences and advice offer inspiration and guidance to aspiring entrepreneurs, highlighting the power of resilience, innovation, and strategic planning.
Don’t miss this exclusive interview with Ray Mountfort, where you’ll find inspiration, practical tips, and a wealth of knowledge to help you raise capital and achieve remarkable success, even amidst challenging circumstances. Learn from a true industry leader who turned adversity into opportunity and emerged stronger than ever.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
